Dexmedetomidine for Laryngeal Mask Airway Insertion
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The investigators attempted to determine the optimal dose of dexmedetomidine required for the
successful insertion of LMA during propofol induction without a neuromuscular blocking agent.